drug screening

Advances in artificial intelligence enable high throughput compound profiling and cell viability analysis. 

3D bioprinted models of the tumor microenvironment could make the preclinical research process more reliable and accelerate translation to the clinic. 

Researchers use retinal organoids to screen drugs and hope to transplant them into the eyes of people with blindness in the coming years.

Learn how scientists use cells from real human intestine to assess gut toxicity and screen drugs.

Researchers redefine cell death in disease and drug discovery.

Cardiologist Sheba Meymandi hopes to prevent the deadly cardiac effects of Chagas disease with increased screening and knowledge of the disease.

Scientists combined engineered E. coli with artificial intelligence to produce effective, high-quality protein and antibody-based drugs at a large scale.

LIVE June 17th, 2021 at 2:30 PM ET
This webinar will discuss recent disease and drug discoveries enabled through screening CRISPR-modified stem cells.

Normal cell and tissue physiology is complex, even without pathologies that arise from myriad sources and impact multiple pathways. Rather than focusing on individual molecular entry points, phenotypic imaging enables a broader understanding of disease outcomes. This webinar will examine advances in imaging and high-content screening modalities to facilitate such understanding.